Table 2

	Percentage with problems (%)
	Mobility	Self-care	Usual activities	Pain/discomfort	Anxiety/depression	EQ-5D index	EQ-5D VAS
Overall with problems	1049 (7.1)	333 (2.2)	643 (4.3)	3681 (24.8)	3012 (20.3)
Gender
Male	5.4	1.8	3.3	19.4	16.0	0.920 ± 0.150	74 ± 15.1
Female	9.0^a	2.7^a	5.6^a	31.2^a	25.4^a	0.870 ± 0.193^a	72.6 ± 16.2^a
Age
18 – 40 years	2.0	0.8	2.2	16.0	16.9	0.933 ± 0.135	74.0 ± 15.2
40 – 65 years	3.9	1.2	2.6	23.6	20.9	0.905 ± 0.165	73.3 ± 15.4
> 65 years	15.4^a	5.0^a	8.8^a	29.0^a	19.5^b	0.873 ± 0.194^a	73.4 ± 16.2
Employment
Employed	1.8	0.3	0.9	19.5	17.3	0.928 ± 0.130	74.3 ± 14.7
Unemployed	10.9^a	3.6^a	6.8^a	28.6^a	22.5^a	0.875 ± 0.195^a	72.6 ± 16.2^a
Education
< 6 years	10.8	3.5	6.6	28.4	22.2	0.876 ± 0.195	72.7 ± 16.6
6-11 years	4.7	1.4	2.9	23.2	19.4	0.909 ± 0.158	73.6 ± 15.1
>11 years	3.6^a	1.0^a	2.2^a	20.2	17.9^a	0.921 ± 0.144^a	74.3 ± 14.1^a
Diabetes duration
< 5 years	4.6	1.4	2.8	21.2	19.7	0.910 ± 0.163	74.0 ± 15.1
5 – 10 years	6.1	1.9	4.0	25.1	19.4	0.901 ± 0.170	73.3 ± 15.6
> 10 years	10.5^a	3.4^a	6.3^a	28.9^a	21.6^b	0.881 ± 0.186^a	72.7 ± 16.1^a
HbA1c
< 7.0 %	7.4	2.3	4.3	24.8	20.6	0.897 ± 0.173	74.1 ± 15.1
≥ 7.0 %	6.6	2.2	4.4	24.8	19.9	0.898 ± 0.174	72.8 ± 15.9^a
BMI
< 25 kg/m²	5.9	2.3	4.0	23.3	21.0	0.900 ± 0.170	73.7 ± 15.3
≥ 25 kg/m²	7.7^a	1.9	4.3	26.0^a	19.7^b	0.898 ± 0.169	73.1 ± 15.7^b
Hypertension
No	2.3	1.1	2.0	23.6	21.4	0.902 ± 0.175	73.4 ± 15.3
Yes	8.2^a	2.5^a	4.9^a	25.2	20.1	0.896 ± 0.173	73.3 ± 15.7
Dyslipidaemia
No	5.9	2.2	4.3	25.1	22.3	0.897 ± 0.167	73.6 ± 15.3
Yes	7.3 ^b	2.3	4.3	24.8	20.0^b	0.897 ± 0.174	73.3 ± 15.6
Nephropathy
No	3.9	1.3	2.5	22.8	19.5	0.909 ± 0.160	74.1 ± 15.2
Yes	12.0^a	3.7^a	7.2^a	27.9^a	21.5‡	0.879 ± 0.190^a	72.2 ± 16.2^a
Retinopathy
No	6.4	2.0	3.9	24.7	19.9	0.899 ± 0.172	73.6 ± 15.4
Yes	9.0^a	3.0^a	5.6^a	25.4	21.4^b	0.891 ± 0.176 c	72.6 ± 16.0^a
Sensory neuropathy
No	6.3	1.9	3.9	24.3	20	0.901 ± 0.168	73.4 ± 15.5
Yes	23.3^a	8.6^a	13.7^a	35.9^a	27.2^a	0.815 ± 0.249^a	71.2 ± 17.4^a
Cardiovascular disease
No	5.1	1.2	2.8	23.5	19.6	0.905 ± 0.162	73.8 ± 15.5
Yes	18.3^a	7.4^a	12.0^a	28.1^a	22.1‡	0.861 ± 0.211^a	71.9 ± 16.6^a
Hypoglycaemia^d
< once/month	6.9	2.2	4.2	24.0	19.4	0.901 ± 0.171	73.6 ± 15.5
≥ once/month	9.7^a	2.5	6.1^c	34.6^a	29.5^a	0.858 ± 0.197^a	70.8 ± 16.4^a
Use of insulin
No	6.9	2.2	4.3	25.2	20.2	0.897 ± 0.174	73.7 ± 15.5
Yes	8.2	2.4	4.4	21.8^c	21.7	0.902 ± 0.166	70.3 ± 16.3^a
Adherence to balanced diet^e
No	6.2	1.8	3.8	25.6	21.1	0.897 ± 0.172	71.4 ± 16.1
Yes	8.0^a	2.7^a	4.9^a	24.3	19.5^b	0.897 ± 0.174	73.5 ± 15.5^a
Physical exercise^e
< 3times/ week	7.9	2.8	5.4	25.2	21.0	0.892 ± 0.183	71.9 ± 15.7
≥ 3tiems / week	6.4^a	1.6^a	3.3^a	24.6	19.5^b	0.903 ± 0.163^a	74.8 ± 15.3^a
SMBG^e
< once/month	5.7	1.8	3.3	23.7	20.3	0.901 ± 0.171	73.2 ± 15.8
≥ once/month	8.0^a	2.6^c	5.0^a	25.5^c	20.3	0.895 ± 0.175^a	73.5 ± 15.5

SMBG: Self Monitoring of Blood Glucose; BMI: Body Mass Index.
^ap < 0.001, ^bp < 0.01, ^cp < 0.05, ^dSelf-reported hypoglycemia within the previous 3 months.
^eAdherence to lifestyle factors within the previous 3 months

Table 2: Percentages of patients with problems in each of the five dimensions of EQ-5D, EQ-5D index and VAS, stratified by clinical characteristics.